Skip to main content

Table 2 Local reactions after autologous E.coli autovaccine

From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial

Subject Erythema Induration Local pain* Itch
No. 1 V32 → V32 → V32 → -
No. 2 V16 → - - -
No. 3 V22 → V23 → V22 -
No. 4 V25 → V25 → - -
No. 5 V29 → V29 → - -
No. 6 V26 → V26 → - V26 →
No. 7 V22 → V22 → V22 V31 →
No. 8 V13 → V13 → - V8/16/25; V27 →
No. 9 V9 → V9 → V17 →- V9
episodes total No. (per 306 injections) 101 (33%) 95 (31%) 27 (8.8%) 30 (9.8%)
episodes/subject [median No., range] 12 (1-26) 10 (0-25) n.a. n.a.
average size [cm, range] 2.5 (2-11) 3.0 (0-11) n.a. n.a.
  1. V32 → = after visit 32 and every following visit; V22 = after visit 22; * = mild in character; n.a. = not applicable